SI2928861T1 - Aminociklobutan derivati, postopek priprave le-teh in uporaba le-teh kot zdravila - Google Patents

Aminociklobutan derivati, postopek priprave le-teh in uporaba le-teh kot zdravila

Info

Publication number
SI2928861T1
SI2928861T1 SI201330607A SI201330607A SI2928861T1 SI 2928861 T1 SI2928861 T1 SI 2928861T1 SI 201330607 A SI201330607 A SI 201330607A SI 201330607 A SI201330607 A SI 201330607A SI 2928861 T1 SI2928861 T1 SI 2928861T1
Authority
SI
Slovenia
Prior art keywords
drugs
preparing same
aminocyclobutane
derivatives
aminocyclobutane derivatives
Prior art date
Application number
SI201330607A
Other languages
English (en)
Inventor
Bernard Vacher
Elodie Blanc
Ronan Depoortere
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of SI2928861T1 publication Critical patent/SI2928861T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201330607A 2012-12-04 2013-12-04 Aminociklobutan derivati, postopek priprave le-teh in uporaba le-teh kot zdravila SI2928861T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1261621A FR2998892B1 (fr) 2012-12-04 2012-12-04 Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
EP13811402.0A EP2928861B1 (fr) 2012-12-04 2013-12-04 Dérivés d'aminocyclobutane, leur procédé de préparation et leur utilisation à titre de médicaments
PCT/EP2013/075481 WO2014086825A1 (fr) 2012-12-04 2013-12-04 Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments

Publications (1)

Publication Number Publication Date
SI2928861T1 true SI2928861T1 (sl) 2017-05-31

Family

ID=48128432

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330607A SI2928861T1 (sl) 2012-12-04 2013-12-04 Aminociklobutan derivati, postopek priprave le-teh in uporaba le-teh kot zdravila

Country Status (31)

Country Link
US (2) US9469601B2 (sl)
EP (1) EP2928861B1 (sl)
JP (1) JP6391586B2 (sl)
KR (1) KR102221928B1 (sl)
CN (2) CN106957285B (sl)
AR (1) AR093787A1 (sl)
AU (1) AU2013354133B2 (sl)
BR (1) BR112015012752B1 (sl)
CA (1) CA2893216C (sl)
CY (1) CY1118841T1 (sl)
DK (1) DK2928861T3 (sl)
ES (1) ES2621896T3 (sl)
FR (1) FR2998892B1 (sl)
HK (1) HK1212968A1 (sl)
HR (1) HRP20170564T1 (sl)
IL (1) IL239146A (sl)
LT (1) LT2928861T (sl)
MA (1) MA38229B1 (sl)
MX (1) MX364556B (sl)
MY (1) MY179886A (sl)
NZ (1) NZ709572A (sl)
PL (1) PL2928861T3 (sl)
PT (1) PT2928861T (sl)
RS (1) RS55916B1 (sl)
RU (1) RU2655919C2 (sl)
SA (1) SA515360518B1 (sl)
SI (1) SI2928861T1 (sl)
TN (1) TN2015000240A1 (sl)
TW (1) TWI603947B (sl)
UA (1) UA114017C2 (sl)
WO (1) WO2014086825A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200136957A (ko) 2018-03-28 2020-12-08 다케다 야쿠힌 고교 가부시키가이샤 헤테로사이클릭 화합물 및 이의 용도
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
WO2021098732A1 (zh) * 2019-11-18 2021-05-27 江苏恩华药业股份有限公司 一种1',2'-二氢-3'h-螺[环丁烷1,4'-异喹啉]-3'-酮衍生物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133924A (en) * 1960-05-31 1964-05-19 Bristol Myers Co Amino-substituted cyclobutane carboxamides
FR2581059B1 (fr) * 1985-04-25 1988-04-22 Pf Medicament Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z)
EP0747348A4 (en) * 1994-02-22 1999-07-07 Asahi Chemical Ind AMINOALKYLCYCLOPROPAN DERIVATIVES
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
WO1998007447A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
ES2253825T3 (es) 1997-09-08 2006-06-01 Warner-Lambert Company Llc Composiciones analgesicas que comprenden compuestos antiepilepticos y procedimientos para usar las mismas.
US6172118B1 (en) * 1998-04-14 2001-01-09 Smithkline Beecham Corporation Compounds
PT1102589E (pt) 1998-07-16 2006-12-29 Memorial Sloan Kettering Inst Composições tópicas compreendendo um analgésico opióide e um antagonista do nmda
WO2000051607A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
WO2003061656A1 (en) 2002-01-16 2003-07-31 Endo Pharmaceuticals Inc. Pharmaceutical composition and method for treating disorders of the central nervous system
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US7687080B2 (en) 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
ES2345857T3 (es) 2007-02-01 2010-10-04 Tibotec Pharmaceuticals Procesos y compuestos intermedios para la preparacion de un inhibidor macrociclico de la proteasa de vhc.
CN101765582A (zh) * 2007-04-26 2010-06-30 奥斯拜客斯制药有限公司 氘标记的氯胺酮
US20090061024A1 (en) 2007-08-27 2009-03-05 Wyeth Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
US8211907B2 (en) 2007-11-28 2012-07-03 Astellas Pharma Inc. Fused indane compound
WO2009092324A1 (en) 2008-01-16 2009-07-30 Hong Kong University Of Science And Technology Oxazolidine derivatives as nmda antagonists
AU2009296457A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
TW201026667A (en) 2008-09-30 2010-07-16 Merz Pharma Gmbh & Co Kgaa Glycine b antagonists
FR2943666B1 (fr) 2009-03-31 2011-04-15 Commissariat Energie Atomique Metallophore derive de nicotianamine et ses procedes de fabrication
FR2944011B1 (fr) * 2009-04-03 2011-05-20 Pf Medicament Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments.
WO2010127856A1 (en) * 2009-05-07 2010-11-11 Grünenthal GmbH Substituted phenyllureas and phenylamides as vanilloid receptor ligands
FR2946535B1 (fr) 2009-06-10 2011-09-09 Neureva Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.
TWI544923B (zh) 2009-12-29 2016-08-11 何應瑞 用於治療神經退化性疾病之醫藥組合物

Also Published As

Publication number Publication date
KR20150091163A (ko) 2015-08-07
MY179886A (en) 2020-11-18
EP2928861B1 (fr) 2017-01-11
MX364556B (es) 2019-04-30
KR102221928B1 (ko) 2021-03-02
US20170065543A1 (en) 2017-03-09
MA38229B1 (fr) 2016-09-30
BR112015012752A2 (pt) 2017-07-11
SA515360518B1 (ar) 2017-05-17
TWI603947B (zh) 2017-11-01
CA2893216A1 (fr) 2014-06-12
ES2621896T3 (es) 2017-07-05
RU2015126104A (ru) 2017-01-10
IL239146A0 (en) 2015-07-30
RS55916B1 (sr) 2017-09-29
JP6391586B2 (ja) 2018-09-19
BR112015012752B1 (pt) 2020-10-27
DK2928861T3 (en) 2017-04-24
PL2928861T3 (pl) 2017-08-31
HK1212968A1 (zh) 2016-06-24
FR2998892B1 (fr) 2015-01-02
JP2016502555A (ja) 2016-01-28
US9469601B2 (en) 2016-10-18
TW201427930A (zh) 2014-07-16
EP2928861A1 (fr) 2015-10-14
UA114017C2 (xx) 2017-04-10
TN2015000240A1 (fr) 2016-10-03
RU2655919C2 (ru) 2018-05-30
CN104854083B (zh) 2017-05-24
AU2013354133A1 (en) 2015-07-23
FR2998892A1 (fr) 2014-06-06
US9687459B2 (en) 2017-06-27
MA38229A1 (fr) 2016-01-29
LT2928861T (lt) 2017-04-25
CN106957285A (zh) 2017-07-18
AR093787A1 (es) 2015-06-24
CN106957285B (zh) 2019-05-03
MX2015006686A (es) 2015-08-10
CY1118841T1 (el) 2018-01-10
CA2893216C (fr) 2021-01-26
CN104854083A (zh) 2015-08-19
AU2013354133B2 (en) 2017-07-06
HRP20170564T1 (hr) 2017-06-16
WO2014086825A1 (fr) 2014-06-12
IL239146A (en) 2017-06-29
US20150315132A1 (en) 2015-11-05
PT2928861T (pt) 2017-04-24
NZ709572A (en) 2019-02-22

Similar Documents

Publication Publication Date Title
HK1203507A1 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
ZA201404625B (en) Polycyclic derivatives, preparation method and medical uses thereof
IL245101B (en) Derivatives of 1,4-cyclohexylamine and processes for their preparation
HK1248214A1 (zh) 新噻吩並嘧啶衍生物、其製備方法及其治療用途
EP2881395A4 (en) PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2742020A4 (en) N1-CYCLIC AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
EP2813495A4 (en) 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF
HK1211849A1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
EP2805954A4 (en) 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
EP2805956A4 (en) GAMBOGIC ACID DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF
EP3078659A4 (en) 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1212968A1 (zh) 氨基環丁烷衍生物、其製備方法及其用作藥物的用途
HUE050104T2 (hu) 3,5N-trihidroxi-alkánamid és származékok: eljárás ennek elõállítására és ennek felhasználása
IL227544A0 (en) Leoplomide and its enantiomers, a method for their preparation and medical uses thereof
AP3759A (en) Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same
EP2889292A4 (en) 2-SUBSTITUTED 2H-1,2,3-TRIAZOLE DERIVATIVE AND METHOD OF MANUFACTURING THEREOF
PL398021A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
PL398018A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
HUP1300393A2 (en) Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
PL398987A1 (pl) (Z)-6-siarczan-6,4'-dihydroksy-7-prenylo-4-metoksyauronu i sposób jego wytwarzania